Xynos Konstantinos Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
5
Insider Sells Sum
$332,188.38

Insider Activity of Xynos Konstantinos

According to the SEC Form 4 filings, Xynos Konstantinos, being in a position of

  1. Chief Medical Officer at Replimune Group, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 32718 shares for $285,661,
    over all time since 2023-05-16, has bought 0 shares, and sold 78248 shares for $681,943.

Biography of Xynos Konstantinos

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $285,6613100

Comparison of Insiders on Amount of Buys and Sells

2026-08-10SaleReplimune Group, Inc.
REPL
Chief Medical Officer
11,447
0.0117%
$12.97$148,468-3.11%
2026-05-18SaleReplimune Group, Inc.
REPL
Chief Medical Officer
14,023
0.0172%
$5.08$71,237+136.93%
2025-11-17SaleReplimune Group, Inc.
REPL
Chief Medical Officer
7,248
0.0096%
$9.10$65,957+8.27%
2025-05-20SaleReplimune Group, Inc.
REPL
Chief Medical Officer
7,952
0.0091%
$8.06$64,093-17.19%
2024-11-18SaleReplimune Group, Inc.
REPL
Chief Medical Officer
7,246
0.0106%
$10.78$78,112-12.77%
2024-06-07SaleReplimune Group, Inc.
REPL
Chief Medical Officer
15,881
0.0245%
$7.50$119,108+36.84%
2024-05-16SaleReplimune Group, Inc.
REPL
Chief Medical Officer
6,367
0.0105%
$6.47$41,194+60.79%
2023-11-16SaleReplimune Group, Inc.
REPL
Chief Medical Officer
7,313
0.0131%
$10.92$79,858-15.6%
2023-05-16SaleReplimune Group, Inc.
REPL
Chief Medical Officer
771
0.0013%
$18.05$13,917-39.05%
Total: 9
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.